Sustained release of targeted cardiac therapy with a replenishable implanted epicardial reservoir

[1]  Soler Rich Robert,et al.  Treatment with mesenchymal stem cells for xerostomia: A new paradigm in cell therapy , 2019, Integrative Clinical Medicine.

[2]  P. Seferovic,et al.  Percutaneous Therapy in Pericardial Diseases. , 2017, Cardiology clinics.

[3]  D J Mooney,et al.  Tough adhesives for diverse wet surfaces , 2017, Science.

[4]  J. Leor,et al.  Left Ventricular Dysfunction Switches Mesenchymal Stromal Cells Toward an Inflammatory Phenotype and Impairs Their Reparative Properties Via Toll-Like Receptor-4 , 2017, Circulation.

[5]  R. Bolli.  Repeated Cell Therapy: A Paradigm Shift Whose Time Has Come , 2017, Circulation research.

[6]  R. Bolli,et al.  Repeated doses of cardiac mesenchymal cells are therapeutically superior to a single dose in mice with old myocardial infarction , 2017, Basic Research in Cardiology.

[7]  William Whyte,et al.  Biomaterial‐Enhanced Cell and Drug Delivery: Lessons Learned in the Cardiac Field and Future Perspectives , 2016, Advanced materials.

[8]  R. Bolli,et al.  Repeated Administrations of Cardiac Progenitor Cells Are Markedly More Effective Than a Single Administration: A New Paradigm in Cell Therapy. , 2016, Circulation research.

[9]  P. Noseworthy,et al.  Trends in percutaneous pericardial access during catheter ablation of ventricular arrhythmias: a single-center experience , 2016, Journal of Interventional Cardiac Electrophysiology.

[10]  C. Hodgkinson,et al.  Emerging Concepts in Paracrine Mechanisms in Regenerative Cardiovascular Medicine and Biology. , 2016, Circulation research.

[11]  Jason A Burdick,et al.  Injectable shear-thinning hydrogels used to deliver endothelial progenitor cells, enhance cell engraftment, and improve ischemic myocardium. , 2015, The Journal of thoracic and cardiovascular surgery.

[12]  S. Fisher,et al.  Stem cell treatment for acute myocardial infarction. , 2015, The Cochrane database of systematic reviews.

[13]  M. Klinker,et al.  Mesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal models. , 2015, World journal of stem cells.

[14]  Conor J. Walsh,et al.  Drug and cell delivery for cardiac regeneration. , 2015, Advanced drug delivery reviews.

[15]  C. Walsh,et al.  Comparison of biomaterial delivery vehicles for improving acute retention of stem cells in the infarcted heart. , 2014, Biomaterials.

[16]  H. Sung,et al.  Combined Usage of Stem Cells in End‐Stage Heart Failure Therapies , 2014, Journal of cellular biochemistry.

[17]  Y. Adler,et al.  DRainage Or Pericardiocentesis alone for recurrent nonmalignant, nonbacterial pericardial effusions requiring intervention: rationale and design of the DROP trial, a randomized, open-label, multicenter study , 2014, Journal of cardiovascular medicine.

[18]  F. Cao,et al.  Selective inhibition of inositol hexakisphosphate kinases (IP6Ks) enhances mesenchymal stem cell engraftment and improves therapeutic efficacy for myocardial infarction , 2014, Basic Research in Cardiology.

[19]  A. Plowright,et al.  Heart regeneration: opportunities and challenges for drug discovery with novel chemical and therapeutic methods or agents. , 2014, Angewandte Chemie.

[20]  David J Mooney,et al.  Injectable, porous, and cell-responsive gelatin cryogels. , 2014, Biomaterials.

[21]  Kelvin S. Ng,et al.  Emerging medical devices for minimally invasive cell therapy. , 2014, Mayo Clinic proceedings.

[22]  Chun-Keung Yu,et al.  Prostaglandin E2 promotes post-infarction cardiomyocyte replenishment by endogenous stem cells , 2014, EMBO molecular medicine.

[23]  L. Martinelli,et al.  Postsurgical intrapericardial adhesions: mechanisms of formation and prevention. , 2013, The Annals of thoracic surgery.

[24]  E. Marbán,et al.  Enhancing retention and efficacy of cardiosphere-derived cells administered after myocardial infarction using a hyaluronan-gelatin hydrogel , 2013, Biomatter.

[25]  P. Lemarchand,et al.  Intramyocardial Delivery of Mesenchymal Stem Cell-Seeded Hydrogel Preserves Cardiac Function and Attenuates Ventricular Remodeling after Myocardial Infarction , 2012, PloS one.

[26]  Darren R. Williams,et al.  Reawakening atlas: chemical approaches to repair or replace dysfunctional musculature. , 2012, ACS chemical biology.

[27]  M. Cevasco,et al.  Ventricular restraint therapy for heart failure: A review, summary of state of the art, and future directions. , 2012, The Journal of thoracic and cardiovascular surgery.

[28]  L. P. Tan,et al.  Hemodynamic contribution of stem cell scaffolding in acute injured myocardium. , 2012, Tissue engineering. Part A.

[29]  Yan Wang,et al.  The influence of chitosan hydrogel on stem cell engraftment, survival and homing in the ischemic myocardial microenvironment. , 2012, Biomaterials.

[30]  Daniel Berman,et al.  Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial , 2012, The Lancet.

[31]  B. Schlosshauer,et al.  The Bispecific SDF1-GPVI Fusion Protein Preserves Myocardial Function After Transient Ischemia in Mice , 2012, Circulation.

[32]  S. Fisher,et al.  Stem cell treatment for acute myocardial infarction. , 2012, The Cochrane database of systematic reviews.

[33]  E. Marbán,et al.  Cardiac cell therapy: where we've been, where we are, and where we should be headed. , 2011, British medical bulletin.

[34]  P. Menasché.  Cardiac cell therapy: lessons from clinical trials. , 2011, Journal of molecular and cellular cardiology.

[35]  P. Macdonald,et al.  Parenteral administration of recombinant human neuregulin‐1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses , 2011, European journal of heart failure.

[36]  L. Gepstein,et al.  A combined cell therapy and in-situ tissue-engineering approach for myocardial repair. , 2011, Biomaterials.

[37]  A. Zeiher,et al.  Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI) , 2002, Clinical research in cardiology : official journal of the German Cardiac Society.

[38]  Ethan Lee,et al.  Pyrvinium, a Potent Small Molecule Wnt Inhibitor, Promotes Wound Repair and Post-MI Cardiac Remodeling , 2010, PloS one.

[39]  P. Pattany,et al.  Bone Marrow Mesenchymal Stem Cells Stimulate Cardiac Stem Cell Proliferation and Differentiation , 2010, Circulation research.

[40]  Randall J Lee,et al.  The use of human mesenchymal stem cells encapsulated in RGD modified alginate microspheres in the repair of myocardial infarction in the rat. , 2010, Biomaterials.

[41]  Jennifer M. Singelyn,et al.  Injectable Materials for the Treatment of Myocardial Infarction and Heart Failure: The Promise of Decellularized Matrices , 2010, Journal of cardiovascular translational research.

[42]  Richard T. Lee,et al.  Protein Therapeutics for Cardiac Regeneration after Myocardial Infarction , 2010, Journal of cardiovascular translational research.

[43]  F. Prósper,et al.  Repeated implantation of skeletal myoblast in a swine model of chronic myocardial infarction. , 2010, European heart journal.

[44]  Tong Hao,et al.  Functional improvement of infarcted heart by co-injection of embryonic stem cells with temperature-responsive chitosan hydrogel. , 2009, Tissue engineering. Part A.

[45]  M. Tendera,et al.  Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem , 2009, European heart journal.

[46]  P. Menasché,et al.  Cell delivery: intramyocardial injections or epicardial deposition? A head-to-head comparison. , 2009, The Annals of thoracic surgery.

[47]  Gordana Vunjak-Novakovic,et al.  Percutaneous Cell Delivery into the Heart Using Hydrogels Polymerizing in Situ , 2009, Cell transplantation.

[48]  S. Grajek,et al.  mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial , 2009 .

[49]  M. Gnecchi,et al.  Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy , 2008, Circulation research.

[50]  S. Dimmeler,et al.  Stem cell technology: The newest breakthroughs in regenerative medicine , 2008 .

[51]  C. Murry,et al.  Systems approaches to preventing transplanted cell death in cardiac repair. , 2008, Journal of molecular and cellular cardiology.

[52]  L. Dougherty,et al.  Ventricular restraint prevents infarct expansion and improves borderzone function after myocardial infarction: a study using magnetic resonance imaging, three-dimensional surface modeling, and myocardial tagging. , 2007, The Annals of thoracic surgery.

[53]  Richard T. Lee,et al.  Local Delivery of Protease-Resistant Stromal Cell Derived Factor-1 for Stem Cell Recruitment After Myocardial Infarction , 2007, Circulation.

[54]  S. Epstein,et al.  Cell-based therapy for myocardial ischemia and infarction: pathophysiological mechanisms. , 2007, Annual review of pathology.

[55]  J. Ingwall,et al.  Evidence supporting paracrine hypothesis for Akt‐modified mesenchymal stem cell‐mediated cardiac protection and functional improvement , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[56]  S. Dymarkowski,et al.  Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial , 2006, The Lancet.

[57]  J. Pilla,et al.  Early postinfarction ventricular restraint improves borderzone wall thickening dynamics during remodeling. , 2005, The Annals of thoracic surgery.

[58]  D. Torella,et al.  Cardiac Stem Cells Possess Growth Factor-Receptor Systems That After Activation Regenerate the Infarcted Myocardium, Improving Ventricular Function and Long-Term Survival , 2005, Circulation research.

[59]  Randall J Lee,et al.  Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. , 2004, Journal of the American College of Cardiology.

[60]  M. Burnett,et al.  Marrow-Derived Stromal Cells Express Genes Encoding a Broad Spectrum of Arteriogenic Cytokines and Promote In Vitro and In Vivo Arteriogenesis Through Paracrine Mechanisms , 2004, Circulation research.

[61]  Mark A Sussman,et al.  Cardiac Stem Cell and Myocyte Aging, Heart Failure, and Insulin-Like Growth Factor-1 Overexpression , 2004, Circulation research.

[62]  H. van Essen,et al.  Intrapericardial Delivery Enhances Cardiac Effects of Sotalol and Atenolol , 2003, Journal of cardiovascular pharmacology.

[63]  N. Fineberg,et al.  Augmentation of Intrapericardial Nitric Oxide Level by a Prolonged-Release Nitric Oxide Donor Reduces Luminal Narrowing After Porcine Coronary Angioplasty , 2002, Circulation.

[64]  Rahul Mehra,et al.  Intrapericardial Therapeutics: A Pharmacodynamic and Pharmacokinetic Comparison Between Pericardial and Intravenous Procainamide Delivery , 2002, Journal of cardiovascular electrophysiology.

[65]  H. van Essen,et al.  Pharmacokinetic advantage of intrapericardially applied substances in the rat. , 2002, The Journal of pharmacology and experimental therapeutics.

[66]  A. Chella,et al.  The management of malignant pericardial effusions using permanently implanted devices. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[67]  R. Verrier,et al.  Intrapericardial beta-adrenergic blockade with esmolol exerts a potent antitachycardic effect without depressing contractility. , 2000, Journal of cardiovascular pharmacology.

[68]  H. Sabbah,et al.  Passive epicardial containment prevents ventricular remodeling in heart failure. , 2000, The Annals of thoracic surgery.

[69]  R. Verrier,et al.  Persistent primary coronary dilation induced by transatrial delivery of nitroglycerin into the pericardial space: a novel approach for local cardiac drug delivery. , 1999, Journal of the American College of Cardiology.

[70]  M. Simons,et al.  Therapeutic myocardial angiogenesis using percutaneous intrapericardial drug delivery , 1999, Clinical cardiology.

[71]  E. Lovell,et al.  New technique for rapid, safe transvenous access into the pericardial space: a novel approach for local cardiac drug delivery , 1998 .